HYDERABAD, MAY 05, 2026: The Second Regulatory Forum between the United States Food and Drug Administration (USFDA) and the Drugs Control Administration (DCA), Telangana was conducted on 5th May, 2026 at the DCA Headquarters, Vengal Rao Nagar, Hyderabad.
USFDA officials Mr. Greg Smith, Country Director; Ms. Lisa Flores, Regulatory Specialist (Pharmaceuticals); Mr. Rafeeq Habeeb, Regulatory Specialist (Pharmaceuticals); and Mr. Dhruv Shah, Senior Technical Advisor, attended the forum.
The regulatory forum served as a knowledge-sharing platform aimed at exchanging and learning best regulatory practices related to the inspection of medical products and the advancement of public health. Several technical sessions on Advanced Good Manufacturing Practices (GMP) concepts were delivered by USFDA investigators during the forum.
DCA officers presented their recent initiatives, inspection approaches, and inspection trends, particularly with regard to Revised Schedule M and sterile manufacturing facility inspections.
The forum significantly enhanced the understanding of DCA inspectors regarding USFDA regulatory requirements and best practices, strengthening collaborative efforts in regulatory practices and public health.
